Literature DB >> 1663515

Characterization of human papillomavirus type 66 from an invasive carcinoma of the uterine cervix.

A R Tawheed1, S Beaudenon, M Favre, G Orth.   

Abstract

Human papillomavirus (HPV) DNA sequences coexisting with HPV16 and HPV45 were cloned from an invasive cervical carcinoma. The cloned HPV was shown to be a novel type, named HPV66, and is related to HPV56 (an HPV detected in cervical cancer). After screening 160 anogenital biopsies, four specimens exhibited histological features of intraepithelial neoplasia and contained HPV66 sequences. Of these, three were found to be associated with another HPV type.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1663515      PMCID： PMC270399          DOI： 10.1128/jcm.29.11.2656-2660.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  26 in total

1.  Plurality of genital human papillomaviruses: characterization of two new types with distinct biological properties.

Authors:  S Beaudenon; D Kremsdorf; S Obalek; S Jablonska; G Pehau-Arnaudet; O Croissant; G Orth
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

2.  Characterization of human papillomavirus type 45, a new type 18-related virus of the genital tract.

Authors:  Z S Naghashfar; N B Rosenshein; A T Lorincz; J Buscema; K V Shah
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

3.  Human papillomavirus type 56: a new virus detected in cervical cancers.

Authors:  A T Lörincz; A P Quinn; M D Goldsborough; P McAllister; G F Temple
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

4.  Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer.

Authors:  S T Cole; R E Streeck
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

5.  Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products.

Authors:  S T Cole; O Danos
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

6.  Molecular cloning and characterization of the DNA of a new human papillomavirus (HPV 30) from a laryngeal carcinoma.

Authors:  T Kahn; E Schwarz; H zur Hausen
Journal:  Int J Cancer       Date:  1986-01-15       Impact factor: 7.396

7.  A novel type of human papillomavirus associated with genital neoplasias.

Authors:  S Beaudenon; D Kremsdorf; O Croissant; S Jablonska; S Wain-Hobson; G Orth
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

8.  Human papillomavirus type 16 DNA sequence.

Authors:  K Seedorf; G Krämmer; M Dürst; S Suhai; W G Röwekamp
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

9.  Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties.

Authors:  J M Short; J M Fernandez; J A Sorge; W D Huse
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

10.  Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.

Authors:  A Schneider-Gädicke; E Schwarz
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598
View more
  10 in total

1.  Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39.

Authors:  M Longuet; S Beaudenon; G Orth
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

2.  Detection of human papillomavirus DNA on the fingers of patients with genital warts.

Authors:  C Sonnex; S Strauss; J J Gray
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

3.  Molecular cloning and nucleotide sequence analysis of a novel human papillomavirus (Type 82) associated with vaginal intraepithelial neoplasia.

Authors:  N Kino; T Sata; Y Sato; M Sugase; T Matsukura
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

4.  Prevalence of human papillomavirus infection in Argentinean women attending two different hospitals prior to the implementation of the National Vaccination Program.

Authors:  Diego Chouhy; Rubén Mamprín D'Andrea; Mercedes Iglesias; Analía Messina; Juan J Ivancovich; Belen Cerda; Diana Galimberti; Hebe Bottai; Adriana A Giri
Journal:  J Med Virol       Date:  2013-01-07       Impact factor: 2.327

5.  Detection of human papillomavirus 16 and 18 DNA in epithelial lesions of the lower genital tract by in situ hybridization and polymerase chain reaction: cervical scrapes are not substitutes for biopsies.

Authors:  N Margall; X Matias-Guiu; M Chillon; P Coll; M Alejo; V Nunes; M Quilez; N Rabella; G Prats; J Prat
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

6.  Human papillomavirus type 1 E4 proteins differing by their N-terminal ends have distinct cellular localizations when transiently expressed in vitro.

Authors:  C Rogel-Gaillard; F Breitburd; G Orth
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis.

Authors:  M C Deau; M Favre; S Jablonska; L A Rueda; G Orth
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

8.  Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes.

Authors:  M V Jacobs; A M de Roda Husman; A J van den Brule; P J Snijders; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

9.  Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Jessica S Vigliotti; Suri Pappu
Journal:  Infect Agent Cancer       Date:  2007-06-05       Impact factor: 2.965

10.  The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa.

Authors:  Christopher Ng'andwe; John J Lowe; Paula J Richards; Lara Hause; Charles Wood; Peter C Angeletti
Journal:  BMC Infect Dis       Date:  2007-07-16       Impact factor: 3.090
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.